The diabetogenic mouse MHC class II molecule I-Ag7 is endowed with a switch that modulates TCR affinity

Journal of Clinical Investigation

Volumn 120, Issue 5, 2010, Pages 1578-1590

  Yoshida, Kenji ^a,c   Corper, Adam L ^a   Herro, Rana ^a   Jabri, Bana ^b   Wilson, Ian A ^a   Teyton, Luc ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c MEIJO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMIC ACID; HLA DQ8 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; T LYMPHOCYTE RECEPTOR;

AMINO ACID ANALYSIS; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CRYSTAL STRUCTURE; DIABETOGENESIS; ELECTRICITY; FEMALE; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RECEPTOR AFFINITY;

ANIMALS; CELL SEPARATION; CRYSTALLOGRAPHY, X-RAY; DIABETES MELLITUS, EXPERIMENTAL; DIMERIZATION; FEMALE; GENETIC COMPLEMENTATION TEST; GENETIC PREDISPOSITION TO DISEASE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; HYBRIDOMAS; KINETICS; MICE; MOLECULAR CONFORMATION; RECEPTORS, ANTIGEN, T-CELL; THYMUS GLAND;

EID: 77951817966     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI41502     Document Type: Article

References (33)

1. Grumet FC, Coukell A, Bodmer JG, Bodmer WF, McDevitt HO. Histocompatibility (HL-A) antigens associated with systemic lupus erythematosus. A possible genetic predisposition to disease. N Engl J Med. 1971;285(4):193-196.
2. Stastny P. Association of the B-cell alloantigen DRw4 with rheumatoid arthritis. N Engl J Med. 1978;298(16):869-871. (Pubitemid 8330170)
3. Todd JA, Bell JI, McDevitt HO. HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature. 1987;329(6140):599-604.
4. Corper AL, et al. A structural framework for deciphering the link between I-Ag7 and autoimmune diabetes. Science. 2000;288(5465):505-511.
5. Stratmann T, et al. The I-Ag7 MHC class II molecule linked to murine diabetes is a promiscuous peptide binder. J Immunol. 2000;165(6):3214-3225.
6. Latek RR, et al. Structural basis of peptide binding and presentation by the type I diabetes-associated MHC class II molecule of NOD mice. Immunity. 2000;12(6):699-710.
7. Yu B, Gauthier L, Hausmann DH, Wucherpfennig KW. Binding of conserved islet peptides by human and murine MHC class II molecules associated with susceptibility to type I diabetes. Eur J Immunol. 2000;30(9):2497-2506.
8. Hennecke J, Carfi A, Wiley DC. Structure of a covalently stabilized complex of a human alphabeta T-cell receptor, influenza HA peptide and MHC class II molecule, HLA-DR1. EMBO J. 2000;19(21):5611-5624.
9. Reinherz EL, et al. The crystal structure of a T cell receptor in complex with peptide and MHC class II. Science. 1999;286(5446):1913-1921. (Pubitemid 129515892)
10. Hovhannisyan Z, et al. The role of HLA-DQ8 beta57 polymorphism in the anti-gluten T-cell response in coeliac disease. Nature. 2008;456(7221):534-538. (Pubitemid 352759011)
11. Yoshida K, et al. Evidence for shared recognition of a peptide ligand by a diverse panel of non-obese diabetic mice-derived, islet-specific, diabetogenic T cell clones. Int Immunol. 2002;14(12):1439-1447. (Pubitemid 36024610)
12. Stratmann T, et al. Susceptible MHC alleles, not background genes, select an autoimmune T cell reactivity. J Clin Invest. 2003;112(6):902-914. (Pubitemid 38063748)
13. Fersht AR. Conformational equilibria in -and -chymotrypsin. The energetics and importance of the salt bridge. J Mol Biol. 1972;64(2):497-509.
14. Schreiber G, Fersht AR. Rapid, electrostatically assisted association of proteins. Nat Struct Biol. 1996;3(5):427-431. (Pubitemid 26139441)
15. Selzer T, Albeck S, Schreiber G. Rational design of faster associating and tighter binding protein complexes. Nat Struct Biol. 2000;7(7):537-541. (Pubitemid 30445907)
16. Shoup D, Szabo A. Role of diffusion in ligand binding to macromolecules and cell-bound receptors. Biophys J. 1982;40(1):33-39.
17. Todd JA, et al. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet. 2007;39(7):857-864.
18. Suri A, Walters JJ, Gross ML, Unanue ER. Natural peptides selected by diabetogenic DQ8 and murine I-A(g7) molecules show common sequence specificity. J Clin Invest. 2005;115(8):2268-2276. (Pubitemid 41135930)
19. Baker FJ, Lee M, Chien YH, Davis MM. Restricted islet-cell reactive T cell repertoire of early pancreatic islet infiltrates in NOD mice. Proc Natl Acad Sci U S A. 2002;99(14):9374-9379. (Pubitemid 34764621)
20. Yang Y, Charlton B, Shimada A, Dal Canto R, Fathman CG. Monoclonal T cells identified in early NOD islet infiltrates. Immunity. 1996;4(2):189-194. (Pubitemid 26093163)
21. Kanagawa O, Vaupel BA, Xu G, Unanue ER, Katz JD. Thymic positive selection and peripheral activation of islet antigen-specific T cells: separation of two diabetogenic steps by an I-A(g7) class II MHC beta-chain mutant. J Immunol. 1998;161(9):4489-4492. (Pubitemid 28492017)
22. Amrani A, Verdaguer J, Serra P, Tafuro S, Tan R, Santamaria P. Progression of autoimmune diabetes driven by avidity maturation of a T-cell population. Nature. 2000;406(6797):739-742.
23. Singer SM, Tisch R, Yang XD, Sytwu HK, Liblau R, McDevitt HO. Prevention of diabetes in NOD mice by a mutated I-Ab transgene. Diabetes. 1998;47(10):1570-1577. (Pubitemid 28445344)
24. Zajonc DM, Savage PB, Bendelac A, Wilson IA, Teyton L. Crystal structures of mouse CD1d-iGb3 complex and its cognate Valpha14 T cell receptor suggest a model for dual recognition of foreign and self glycolipids. J Mol Biol. 2008;377(4):1104-1116.
25. Garcia KC, et al. Alphabeta T cell receptor interactions with syngeneic and allogeneic ligands: affinity measurements and crystallization. Proc Natl Acad Sci U S A. 1997;94(25):13838-13843.
26. Schatz PJ. Use of peptide libraries to map the substrate specificity of a peptide-modifying enzyme: a 13 residue consensus peptide specifies biotinylation in Escherichia coli. Biotechnology. 1993;11(10):1138-1143.
27. Vagin A, Teplyakov A. MOLREP: an automated program for molecular replacement. J Appl Crystallogr. 1997;30(Pt 6):1022-1025. (Pubitemid 127485985)
28. Brunger AT, et al. Crystallography & NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr D Biol Crystallogr. 1998;54(Pt 5):905-921. (Pubitemid 28443603)
29. Emsley P, Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr. 2004;60(Pt 12 Pt 1):2126-2132. (Pubitemid 41742764)
30. Adams PD, et al. PHENIX: building new software for automated crystallographic structure determination. Acta Crystallogr D Biol Crystallogr. 2002;58(Pt 11):1948-1954.
31. Laskowski RA, MacArthur MW, Moss DS, Thornton JM. PROCHECK: a program to check the stereochemical quality of protein structures. J Appl Crystallogr. 1993;26:283-291.
32. Vriend G. WHAT IF: a molecular modeling and drug design program. J Mol Graph. 1990;8(1):52-56, 29.
33. McCoy AJ Grosse-Kunstleve RW, Adams PD Winn MD, Storoni LC Read RJ. Phaser crystallographic software. J Appl Crystallogr. 2007;40(Pt 4):658-674.